Literature DB >> 4045036

Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history.

C P Taliercio, J B Seward, D J Driscoll, L D Fisher, B J Gersh, A J Tajik.   

Abstract

The clinical profile and course of documented cases of idiopathic dilated cardiomyopathy in children have been poorly characterized. Twenty-four patients (median age 2 years, range less than 1 month to 18 years) with idiopathic dilated cardiomyopathy were identified from Mayo Clinic records from 1973 to 1982. The most common presentation was congestive heart failure (92% of patients). Echocardiography (22 patients) generally revealed a dilated left ventricle with reduced fractional shortening (mean 14%) and ejection fraction (mean 26%). Two-dimensional echocardiographic evidence of left ventricular thrombus was present in 3 (23%) of 13 patients. Median cardiac index and left ventricular end-diastolic pressure (19 patients) were 2.5 liters/min per m2 and 22 mm Hg, respectively. Myocardial biopsy in eight patients showed nonspecific findings without active inflammation or evidence of endocardial fibroelastosis. On follow-up (mean duration 33 months, range 0 to 149), systemic arterial embolism had occurred in 2 (8%) of 24 patients. Fifteen of 24 patients had died (63% survival at 1 year and 34% survival at 5 years of follow-up). The cause of death was congestive heart failure in 11, complications after cardiac transplantation in 3 and sudden cardiac death in 1. Nine patients are alive at a mean follow-up time of 65 months (range 26 to 149); five are asymptomatic. Serial determination of left ventricular systolic function, available in all survivors, showed improvement in six patients and no significant change in three. Severe mitral insufficiency was present only in patients who ultimately died. A recent viral syndrome was noted more frequently in patients who survived.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 4045036     DOI: 10.1016/s0735-1097(85)80319-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  26 in total

1.  Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy.

Authors:  P Acar; P Merlet; L Iserin; D Bonnet; D Sidi; A Syrota; J Kachaner
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long-term follow-up study.

Authors:  M G Modena; N Muia; F A Sgura; R Molinari; A Castella; R Rossi
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

3.  Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.

Authors:  Melanie D Everitt; Lynn A Sleeper; Minmin Lu; Charles E Canter; Elfriede Pahl; James D Wilkinson; Linda J Addonizio; Jeffrey A Towbin; Joseph Rossano; Rakesh K Singh; Jacqueline Lamour; Steven A Webber; Steven D Colan; Renee Margossian; Paul F Kantor; John L Jefferies; Steven E Lipshultz
Journal:  J Am Coll Cardiol       Date:  2014-02-19       Impact factor: 24.094

4.  The remarkable effect of ivabradine in two adolescents with dilated cardiomyopathy.

Authors:  Sunaina Parsons; Andrew L Clark; John G F Cleland
Journal:  Clin Res Cardiol       Date:  2014-06-12       Impact factor: 5.460

5.  Pediatric patients hospitalized with myocarditis: a multi-institutional analysis.

Authors:  Darren Klugman; John T Berger; Craig A Sable; Jianping He; Sachin G Khandelwal; Anthony D Slonim
Journal:  Pediatr Cardiol       Date:  2010-02       Impact factor: 1.655

6.  Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.

Authors:  Christophe Maunoury; Philippe Acar; Daniel Sidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-23       Impact factor: 9.236

7.  Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic Review.

Authors:  Jorge A Alvarez; James D Wilkinson; Steven E Lipshultz
Journal:  Prog Pediatr Cardiol       Date:  2007-09-01

8.  Reversible cardiomyopathy caused by an uncommon form of congenital adrenal hyperplasia.

Authors:  A S Al Jarallah
Journal:  Pediatr Cardiol       Date:  2004 Nov-Dec       Impact factor: 1.655

9.  Quinapril inhibits progression of heart failure and fibrosis in rats with dilated cardiomyopathy after myocarditis.

Authors:  Wen Juan; Mikio Nakazawa; Kenichi Watanabe; Meilei Ma; Mir I I Wahed; Go Hasegawa; Makoto Naito; Tadashi Yamamoto; Koichi Fuse; Kiminori Kato; Makoto Kodama; Yoshifusa Aizawa
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

10.  The usefulness of surface electrocardiogram as a prognostic predictor in children with idiopathic dilated cardiomyopathy.

Authors:  June Huh; Chung Il Noh; Yong Soo Yun
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.